LONDON (Reuters) – As speculation about interest rate rises and policy ‘normalization’ in the euro zone, Japan, Britain and China falls away rapidly, the U.S. Federal Reserve’s now lonely monetary tightening has suddenly supercharged the dollar.
(Reuters) – Tesla Inc chief Elon Musk’s refusal to answer “boring” Wall Street questions about the electric car maker’s financial condition sent shares down as much as 7 percent on Thursday and spurred concerns about its ability to raise money in the future.
BERLIN (Reuters) – German healthcare group Fresenius SE said on Thursday its legal battle with Akorn over its canceled $4.7 billion takeover could drag on into 2019 as it posted a slight decline in quarterly profit hurt by a strong euro.
(Reuters) – U.S. stock indexes opened lower on Thursday as investors remained on edge about U.S.-China trade talks, while the latest round of earnings added little cheer.
WASHINGTON (Reuters) – The U.S. trade deficit narrowed sharply in March as exports increased to a record high amid a surge in deliveries of commercial aircraft and soybeans, bolstering the economy’s outlook heading into the second quarter.
(Reuters) – Tesla Inc Chief Executive Elon Musk’s refusal to take questions from analysts about the electric car maker’s financial condition drew sharp criticism from Wall Street analysts and investors on Thursday, pushing its stock down 7 percent.
Amazon is extremely unhappy over a Seattle tax proposal that would set it back …read more […]
(Reuters) – U.S. indexes were on track to open lower on Thursday as investors remained on edge about U.S.-China trade talks, while the latest round of earnings added little cheer.
(Reuters) – U.S. stock index futures were flat on Thursday as investors remained on edge about the U.S.-China trade talks, while the latest round of earnings added little cheer.
Israel’s heavily indebted Teva Pharmaceutical Industries (TEVA.TA) on Thursday raised its financial outlook for 2018 after reporting a smaller than expected drop in first-quarter net profit and revenue. Teva also said that while it does not expect to receive approval for its migraine treatment fremanezumab by mid-June, as had been hoped, it does expect the key drug to gain approval in time for launch before the end of 2018. Analysts had forecast Teva (TEVA.N) would earn 67 cents a share excluding one-offs on revenue of $4.8 billion, according to Thomson Reuters I/B/E/S. …read more […]
Using technology-assisted review (TAR) technology in the U.S. v. Cohen privilege review could potentially expedite the process, while offering transparency around decision-making. …read more […]
FRANKFURT (Reuters) – Europe’s economic slowdown came sooner than expected and factors holding back growth may persist in the near term but the European Central Bank is still making “substantial” progress in lifting inflation, ECB Chief Economist Peter Praet said.
DERBY, England (Reuters) – Rolls-Royce would be interested in bidding to provide a new engine for the United State’s B-52 bombers, said its CEO, should authorities proceed with a project to update the jets.
FRANKFURT (Reuters) – The European Central Bank has made “substantial” progress in lifting inflation but its work is not yet done and requires patience from policymakers, ECB Chief Economist Peter Praet said on Thursday.
(Reuters) – Canadian plane and train maker Bombardier Inc has agreed to sell its Toronto aircraft assembly site to a pension fund as it strives to raise extra cash under a five-year recovery plan.
Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.
